ha 1004 has been researched along with Leukemia, Erythroblastic, Acute in 2 studies
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rinaudo, MS | 1 |
| Su, K | 1 |
| Falk, LA | 1 |
| Halder, S | 1 |
| Mufson, RA | 1 |
| Katayama, N | 1 |
| Nishikawa, M | 1 |
| Minami, N | 1 |
| Shirakawa, S | 1 |
2 other studies available for ha 1004 and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Apoptosis; Base Sequence; Dactinomycin; Gene Expressi | 1995 |
Putative involvement of protein kinase C in proliferation of human myeloid progenitor cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Alkaloids; Bone Marrow; Cell Division; Cell Li | 1989 |